Hot Features
プレミアム
Acrivon Therapeutics Inc (ACRV)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -13.73k | 24.57k | Sale to Issuer | 1.79 | 2.02M | -0.68% |
| 2026-05-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99.00 | 190.08 | Sale to Issuer | 1.92 | 3.91k | -2.47% |
| 2026-05-14 | Dr. Erick GamelinChief Development Officer | -404.00 | 775.68 | Sale to Issuer | 1.92 | 11.90k | -3.28% |
| 2026-05-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184.00 | 353.28 | Sale to Issuer | 1.92 | 25.95k | -0.70% |
| 2026-05-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490.00 | 940.80 | Sale to Issuer | 1.92 | 310.30k | -0.16% |
| 2026-05-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -1.25k | 2.41k | Sale to Issuer | 1.92 | 1.99M | -0.06% |
| 2026-04-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558.00 | 993.24 | Sale to Issuer | 1.78 | 25.51k | -2.14% |
| 2026-02-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -14.27k | 21.83k | Sale to Issuer | 1.53 | 1.99M | -0.71% |
| 2026-02-14 | Ms. Katharine PetersonVP of Finance & Accounting | -116.00 | 189.08 | Sale to Issuer | 1.63 | 4.01k | -2.81% |
| 2026-02-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -217.00 | 353.71 | Sale to Issuer | 1.63 | 24.17k | -0.89% |
| 2026-02-14 | Dr. Erick GamelinChief Development Officer | -471.00 | 767.73 | Sale to Issuer | 1.63 | 11.06k | -4.09% |
| 2026-02-14 | Dr. Eric J. DevroeCOO | -723.00 | 1.18k | Sale to Issuer | 1.63 | 68.33k | -1.05% |
| 2026-02-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -1.30k | 2.12k | Sale to Issuer | 1.63 | 1.96M | -0.07% |
| 2026-02-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -579.00 | 943.77 | Sale to Issuer | 1.63 | 309.12k | -0.19% |
| 2026-01-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -659.00 | 1.30k | Sale to Issuer | 1.98 | 23.76k | -2.70% |
| 2026-01-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | 49.00k | 82.12k | 買い | 1.68 | 1.97M | 2.56% |
| 2026-01-14 | Dr. Adam D. LevyCFO & Principal Financial Officer | 8.83k | 15.00k | 買い | 1.70 | 13.75k | 179.73% |
| 2026-01-13 | Dr. Eric J. DevroeCOO | 10.00k | 17.22k | 買い | 1.72 | 66.96k | 17.56% |
| 2025-11-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -19.90k | 45.78k | Sale to Issuer | 2.30 | 1.92M | -1.03% |
| 2025-11-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99.00 | 221.76 | Sale to Issuer | 2.24 | 4.12k | -2.35% |
| 2025-11-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184.00 | 412.16 | Sale to Issuer | 2.24 | 22.52k | -0.81% |
| 2025-11-14 | Dr. Erick GamelinChief Development Officer | -403.00 | 902.72 | Sale to Issuer | 2.24 | 10.28k | -3.77% |
| 2025-11-14 | Dr. Eric J. DevroeCOO | -613.00 | 1.37k | Sale to Issuer | 2.24 | 56.96k | -1.06% |
| 2025-11-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -59.77k | 133.87k | Sale to Issuer | 2.24 | 1.89M | -3.07% |
| 2025-11-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490.00 | 1.10k | Sale to Issuer | 2.24 | 308.03k | -0.16% |
| 2025-10-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558.00 | 1.01k | Sale to Issuer | 1.81 | 20.18k | -2.69% |
| 2025-10-01 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -284.00 | 514.04 | Sale to Issuer | 1.81 | 20.73k | -1.35% |
| 2025-08-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -19.91k | 26.27k | Sale to Issuer | 1.32 | 1.82M | -1.08% |
| 2025-08-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99.00 | 137.61 | Sale to Issuer | 1.39 | 4.22k | -2.29% |
| 2025-08-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184.00 | 255.76 | Sale to Issuer | 1.39 | 20.05k | -0.91% |
| 2025-08-14 | Dr. Erick GamelinChief Development Officer | -403.00 | 560.17 | Sale to Issuer | 1.39 | 9.43k | -4.10% |
| 2025-08-14 | Dr. Eric J. DevroeCOO | -613.00 | 852.07 | Sale to Issuer | 1.39 | 55.49k | -1.09% |
| 2025-08-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -59.77k | 83.07k | Sale to Issuer | 1.39 | 1.80M | -3.21% |
| 2025-08-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490.00 | 681.10 | Sale to Issuer | 1.39 | 306.85k | -0.16% |
| 2025-08-01 | Dr. Adam D. LevyCFO & Principal Financial Officer | -1.16k | 1.47k | Sale to Issuer | 1.26 | 4.91k | -19.15% |
| 2025-07-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558.00 | 736.56 | Sale to Issuer | 1.32 | 20.34k | -2.67% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
